Last updated on: 3/10/2009 | Author: ProCon.org

Mark A. Ware, MD, MSc Biography

Title:
Assistant Professor in Family Medicine and Anesthesia at McGill University
Position:
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“Crude preparations of herbal cannabis have been used for thousands of years to treat many symptoms, including pain, spasms, and nausea…

Cannabis has not yet been formally evaluated in clinical trials, but safety and efficacy studies are under way and further studies should be designed and conducted. Without such trials it is premature to consider prescribing cannabis, but based on what is known of a drug that has been around for thousands of years, based on the safety data generated from 2 generations of recreational users, and based on the mechanism of action of cannabinoids, it is reasonable for family physicians to become more familiar with cannabis. Its undignified position as a drug of abuse with no known medical value deserves to be reconsidered.”

“Is There a Role for Marijuana in Medical Practice?,” Canadian Family Physician, Dec. 2006

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Assistant Professor, Family Medicine and Anesthesia, McGill University
  • Associate Medical Director, McGill University Health Centre Pain Clinic
  • Practitioner, Pain Medicine, Montreal General Hospital and Montreal Neurological Institute
  • Member, Royal College of Physicians (MRCP)
  • Principle Investigator, Community Research Initiative of Toronto (CRIT)
  • Principal Investigator, “Cannabis for the Management of Pain: Assessment of Safety Study” (COMPASS) trial
  • Scientific Director, Canadian Consortium for the Investigation of Cannabinoids (CCIC)
  • Member, International Cannabinoid Research Society
  • Member, Canadian Pain Society
  • Former Director of Clinical Research, McGill University Health Centre Pain Clinic
  • Recipient, Pfizer Canada Neuropathic Pain Research Awards, 2008
  • Recipient, MUHC Research Institute Equipment Competition Grant, 2003
  • Recipient, The Louise Edwards Foundation Award for Pain Research, 2003
Education:
  • MSc, Epidemiology, London School of Hygiene and Tropical Medicine, 1999
  • MD, University of the West Indies (Kingston, Jamaica), year unknown
Other:
  • Born in London, England in 1964 and raised in Jamaica